Fapon Biopharma Introduces FP008 at Biotech Showcase: A Safer and More Effective Immunotherapy for Refractory Cancers
SAN FRANCISCO,Jan. 2,2025-- Fapon Biopharma,an innovator in developing therapeutic antibodies and fusion proteins,will present its latest breakthrough immunocytokine,FP008,on Jan 14,2025,at the Biote